Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal cannabis for symptom control and quality of life in advanced cancer
ACTRN12619001534178Phase 2Recruiting
- Sponsor
- Olivia Newton-John Cancer Research Institute
- Start
- Sep 2020
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cancer comparing Medicinal cannabis with Placebo (2 arms). Primary endpoints: Phase 1 primary composite outcome and Phase 2 primary outcome. Started Sep 2020; status: recruiting.
02
Drugs
cannabis
03
Conditions
cancer
Beyond the preview
Go deeper on ACTRN12619001534178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001534178.